Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum. 2018

Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi 110067, India.

Malaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoacyl-tRNA synthetases (Pf-aaRSs) drive protein translation and are potent targets for development of next-generation antimalarials. Here, we detail advances made in structural-biology-based investigations in Pf-aaRSs and discuss their distribution of druggable pockets. This review establishes a platform for systematic experimental dissection of malarial parasite aaRSs as a new focus for sustained drug development efforts against malaria.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000604 Amino Acyl-tRNA Synthetases A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS. Amino Acyl T RNA Synthetases,Amino Acyl-tRNA Ligases,Aminoacyl Transfer RNA Synthetase,Aminoacyl-tRNA Synthetase,Transfer RNA Synthetase,tRNA Synthetase,Acyl-tRNA Ligases, Amino,Acyl-tRNA Synthetases, Amino,Amino Acyl tRNA Ligases,Amino Acyl tRNA Synthetases,Aminoacyl tRNA Synthetase,Ligases, Amino Acyl-tRNA,RNA Synthetase, Transfer,Synthetase, Aminoacyl-tRNA,Synthetase, Transfer RNA,Synthetase, tRNA,Synthetases, Amino Acyl-tRNA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D058990 Molecular Targeted Therapy Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease. Targeted Molecular Therapy,Molecular Targeted Therapies,Molecular Therapy, Targeted,Targeted Molecular Therapies,Targeted Therapy, Molecular,Therapy, Molecular Targeted,Therapy, Targeted Molecular

Related Publications

Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
December 2009, BMC genomics,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
April 2016, Malaria journal,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
February 2016, The FEBS journal,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
March 2013, Chembiochem : a European journal of chemical biology,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
January 2003, Science (New York, N.Y.),
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
January 1999, Antimicrobial agents and chemotherapy,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
January 2014, PloS one,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
March 2014, The Biochemical journal,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
February 2012, International journal for parasitology,
Yogavel Manickam, and Rini Chaturvedi, and Palak Babbar, and Nipun Malhotra, and Vitul Jain, and Amit Sharma
June 2000, The EMBO journal,
Copied contents to your clipboard!